Candel Therapeutics, Inc. Common Stock

CADLNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
8.51 USD
↘ 0.76 (8.20%)AT CLOSE (11:59 AM EDT)
8.39
↘ 0.13 (1.47%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
8.39
↘ 0.13 (1.47%)
🔴Market: CLOSED
Open?$9.18
High?$9.24
Low?$8.34
Prev. Close?$9.27
Volume?2.0M
Avg. Volume?2.1M
VWAP?$8.75
Rel. Volume?0.99x
Bid / Ask
Bid?$7.18 × 100
Ask?$9.60 × 100
Spread?$2.42
Midpoint?$8.39
Valuation & Ratios
Market Cap?623.5M
Shares Out?73.3M
Float?42.3M
Float %?77.0%
P/E Ratio?N/A
P/B Ratio?4.52
EPS?-$0.74
Dividend?0.00%
Ex-Dividend?N/A

Candel Therapeutics, Inc. Common Stock (CADL) trades at $8.51 per share. CADL shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. CADL is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
55
Market Cap
623.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.candeltx.com
Listed
2021-07-27
Address
117 KENDRICK STREET
NEEDHAM, MA 02494
Phone: 617-916-5445
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
95
Momentum?
23
Short Sent.?
42
Piotroski F-Score?0/9Weak
Altman Z-Score?4.41Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?34.13%Squeeze Risk
Short Interest?14.4M
Days to Cover?5.5
Free Float42.3M
Avg Daily Volume2.6M
Settlement Date2026-05-15
Financial Health
Current Ratio?28.05Strong
Quick Ratio?28.05Strong
Cash Ratio?27.63Strong
Debt/Equity?0.34Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
40
4.52FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-39.4%WEAK▾
ROA?
S&P
3
-27.0%WEAK▾
Cash Flow & Enterprise
FCF?$-48991000
Enterprise Value?$476.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist